Skip to main content

Table 1 Baseline characteristics of women without cancer and women with local or systemic cancer

From: Responses to fertility treatment among patients with cancer: a retrospective cohort study

Characteristics at cycle start No Cancer (n = 664) Local Cancer (n = 105) Systemic Cancer (n = 42)
Woman’s Age at Stimulation, years (mean ± SD) 34.6 ± 4.2 33.6 ± 4.8 27.1 ± 6.4
Baseline Antral Follicle Count (mean ± SD) (missing, n = 48) 9.4 ± 7.2 10.1 ± 7.4 7.3 ± 7.5
AMH, ng/mL (mean ± SD) 3.4 ± 3.3 2.8 ± 2.7 2.0 ± 2.2
Cycle Day 2–4 FSH, mIU/mL (mean ± SD) (missing, n = 91) 7.2 ± 2.3 9.6 ± 19.8 9.1 ± 6.3
Woman’s BMI at Stimulation, kg/m2 (mean ± SD) 25.7 ± 4.2 26.0 ± 6.3 24.9 ± 5.9
Woman’s Race (n [%])
 Caucasian 466 (70.2%) 88 (86.2%) 36 (85.7%)
 Other 198 (29.8%) 14 (13.7%) 6 (14.3%)
Current Smoker (n [%]) 17 (2.6%) 6 (5.7%) 0 (0%)
Gravida (n [%]) 186 (28.3%) 35(33.3%) 7 (16.7%)
Cycle Type (n [%])
 GnRH antagonist 88 (13.3%) 103 (98.1%) 36 (85.7%)
 Down-regulation 533 (80.3%) 1 (1.0%) 4 (9.5%)
 Gonadotropin only 3 (0.5%) 1 (1.0%) 2 (4.8%)
 Poor-responder protocols 40 (6.0%) 0 (0%) 0 (0%)
Start of Stimulation (n [%])
 Conventional/Early Follicular 664 (100.0%) 84 (80.0%) 25 (59.5%)
 Random Start 0 (0%) 16 (14.3%) 17 (40.5%)
  Late Follicular 0 (0%) 3 (2.9%) 2 (4.8%)
  Luteal 0 (0%) 7 (6.7%) 5 (11.9%)
Total Motile Post-wash Sperm Count, 106 (mean ± SD) 5.66 ± 16.88 28.9 ± 33.4 34.8 ± 41.5
ICSI (n [%]) 547 (85.6%) 21 (21.7%) 4 (11.4%)